GlassScript

Republic Spine

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$5.6Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
63clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.0M
2020 $971K
2021 $1.2M
2022 $624K
2023 $632K
2024 $567K
2025 $628K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Orthopaedic Surgery of The Spine $2.5M
Neurological Surgery $2.0M
Orthopaedic Surgery $1.1M
Pediatric Orthopaedic Surgery $1,866
Surgery $300

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Lawrence Babat Nashville, TN Orthopaedic Surgery of The Spine $881,947.07
Simon Chao North Easton, MA Orthopaedic Surgery $878,175.73
Daniel Husted Stuart, FL Orthopaedic Surgery of The Spine $828,998.40
Timur Urakov Miami, FL Neurological Surgery $603,700.00
Henry Fabian Steamboat Springs, CO Orthopaedic Surgery of The Spine $433,867.47
Luis Duarte San Angelo, TX Neurological Surgery $356,856.75
Chine Logan Nashville, TN Neurological Surgery $292,798.31
Frank Holladay Kansas City, KS Neurological Surgery $266,168.33
Scott Katzman West Orange, NJ Orthopaedic Surgery $175,238.82
Christopher Aho Whittier, CA Neurological Surgery $174,609.43

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.